OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic engineering approaches to improve posttranslational modification of biopharmaceuticals in different production platforms
Thomas Amann, Valerie Schmieder, Helene Faustrup Kildegaard, et al.
Biotechnology and Bioengineering (2019) Vol. 116, Iss. 10, pp. 2778-2796
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
Nagesh K. Tripathi, Ambuj Shrivastava
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 445

Organic acids as antimicrobial food agents: applications and microbial productions
Hasan B. Coban
Bioprocess and Biosystems Engineering (2019) Vol. 43, Iss. 4, pp. 569-591
Closed Access | Times Cited: 168

Current Trends in the Analysis of Post-translational Modifications
Dávid Virág, Borbála Dalmadi-Kiss, Károly Vékey, et al.
Chromatographia (2019) Vol. 83, Iss. 1, pp. 1-10
Open Access | Times Cited: 79

Biomimetic peptide conjugates as emerging strategies for controlled release from protein-based materials
Juthatip Manissorn, Jaturong Promsuk, Kittikhun Wangkanont, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1

Chlorella vulgaris Extract as a Serum Replacement That Enhances Mammalian Cell Growth and Protein Expression
Jian Yao Ng, Mei Ling Chua, Chi Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 55

Engineering challenges in therapeutic protein product and process design
Maria M. Papathanasiou, Cleo Kontoravdi
Current Opinion in Chemical Engineering (2019) Vol. 27, pp. 81-88
Open Access | Times Cited: 46

Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control
Peter Eisenhut, Nicolas Marx, Giulia Borsi, et al.
New Biotechnology (2023) Vol. 79, pp. 1-19
Open Access | Times Cited: 13

Strategies for tailoring pH performances of glycoside hydrolases
Shufang Li, Feng Cheng, Yajun Wang, et al.
Critical Reviews in Biotechnology (2021) Vol. 43, Iss. 1, pp. 121-141
Closed Access | Times Cited: 27

Systematic use of synthetic 5′-UTR RNA structures to tune protein translation improves yield and quality of complex proteins in mammalian cell factories
Peter Eisenhut, Aman Mebrahtu, Mona Moradi Barzadd, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 20, pp. e119-e119
Open Access | Times Cited: 29

Glycoengineering Chinese hamster ovary cells: a short history
Roberto Donini, Stuart M. Haslam, Cleo Kontoravdi
Biochemical Society Transactions (2021) Vol. 49, Iss. 2, pp. 915-931
Open Access | Times Cited: 24

A Markov model of glycosylation elucidates isozyme specificity and glycosyltransferase interactions for glycoengineering
Chenguang Liang, Austin W.T. Chiang, Anders Holmgaard Hansen, et al.
Current Research in Biotechnology (2020) Vol. 2, pp. 22-36
Open Access | Times Cited: 27

A solution to the long-standing problem of actin expression and purification
Ceron RH, Peter J. Carman, Grzegorz Rębowski, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 41
Open Access | Times Cited: 15

So you want to express your protein in Escherichia coli?
Aatir A. Tungekar, Angel Castillo-Corujo, Lloyd W. Ruddock
Essays in Biochemistry (2021) Vol. 65, Iss. 2, pp. 247-260
Open Access | Times Cited: 18

Current genetic engineering strategies for the production of antihypertensive ACEI peptides
Carolina Gomes, Diana Ferreira, João P. F. Carvalho, et al.
Biotechnology and Bioengineering (2020) Vol. 117, Iss. 8, pp. 2610-2628
Closed Access | Times Cited: 17

CRISPR-Cas13d for Gene Knockdown and Engineering of CHO Cells
Chih‐Che Shen, Mei‐Wei Lin, Bao Khanh Thi Nguyen, et al.
ACS Synthetic Biology (2020) Vol. 9, Iss. 10, pp. 2808-2818
Closed Access | Times Cited: 17

Novel human cell expression method reveals the role and prevalence of posttranslational modification in nonmuscle tropomyosins
Peter J. Carman, Kyle R. Barrie, Roberto Domínguez
Journal of Biological Chemistry (2021) Vol. 297, Iss. 4, pp. 101154-101154
Open Access | Times Cited: 14

Soft‐sensors application for automated feeding control in high‐throughput mammalian cell cultures
Iván Martínez‐Monge, Carlos A. Martínez, Marianne Decker, et al.
Biotechnology and Bioengineering (2022) Vol. 119, Iss. 4, pp. 1077-1090
Open Access | Times Cited: 9

Nature as blueprint: Global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells
Nadja Raab, Nikolas Zeh, Robin Kretz, et al.
Metabolic Engineering (2024) Vol. 83, pp. 110-122
Closed Access | Times Cited: 1

Production of Biopharmaceuticals on Genetically Modified Organisms
Sandipan Jana, Barun Das Gupta, Amit Kar, et al.
(2024), pp. 91-101
Closed Access | Times Cited: 1

A pooled CRISPR/AsCpf1 screen using paired gRNAs to induce genomic deletions in Chinese hamster ovary cells
Valerie Schmieder, Neža Novak, Heena Dhiman, et al.
Biotechnology Reports (2021) Vol. 31, pp. e00649-e00649
Open Access | Times Cited: 9

One‐step production of fully biotinylated and glycosylated human Fc gamma receptors
M.S. Kang, Zening Wang, Xin Ge
Biotechnology Progress (2023) Vol. 40, Iss. 1
Closed Access | Times Cited: 3

Recent developments in miRNA based recombinant protein expression in CHO
Masoume Bazaz, Ahmad Adeli, Mohammad Azizi, et al.
Biotechnology Letters (2022) Vol. 44, Iss. 5-6, pp. 671-681
Closed Access | Times Cited: 5

Gene switch for l‐glucose‐induced biopharmaceutical production in mammalian cells
Tobias Strittmatter, Sabina Egli, Adrian Bertschi, et al.
Biotechnology and Bioengineering (2021) Vol. 118, Iss. 6, pp. 2220-2233
Closed Access | Times Cited: 6

Next-Generation Cell Engineering Platform for Improving Recombinant Protein Production in Mammalian Cells
Sung Wook Shin, Minji Kyeong, Jae Seong Lee
Cell engineering (2021), pp. 189-224
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top